News & Publications - Page 2 of 2

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

  • KemPharm to Present at Upcoming Investor Conferences

  • KemPharm Announces FDA Approval of Apadaz™

  • MoneyShow Orlando Conference

  • KP415 – APSARD 2018

  • KP201/IR – AAPM 2017

  • KP511 – AAPM 2017

  • KP511 – ICOO 2016

  • KP201/IR – ICOO 2016

  • KP201/IR – ICOO 2016